RSNA 2014 

Abstract Archives of the RSNA, 2014


RC420B

SABR for Liver Oligometastases

Refresher/Informatics

Presented on December 2, 2014
Presented as part of RC420: Role of Stereotactic Ablative Radiotherapy (SABR) and Interventional Radiology in the Management of Oligometastases

Participants

Michael Lock MD, Presenter: Research Consultant, Accuray Incorporated

LEARNING OBJECTIVES

1) Discuss the reason primary and secondary liver cancer will become an important and growing proportion of patients seen in your clinic. 2) Review the rationale and outcome for radiotherapy in oligometastatic disease. 3) Compare the various methods to treat liver lesions in terms of evidence, outcome and practicality. 4) Understand the problems and solutions for motion management and image-guidance in this area. Review the options and selection of technology 5) Understand why we need t.o be aware of new toxicities and safety parameters.

ABSTRACT

ID: 20130102 (Track 20) Title: SABR for Liver Oligometastases The learner will be able to: 1. discuss the reason primary and secondary liver cancer will become an important and growing proportion of patients seen in your clinic. 2. review the rationale and outcome for radiotherapy in oligometastatic disease 3. compare the various methods to treat liver lesions in terms of evidence, outcome and practicality 4. understand the problems and solutions for motion management and image-guidance in this area. Review the options and selection of technology 5. understand why we need to be aware of new toxicities and safety parameters.  

Cite This Abstract

Lock, M, SABR for Liver Oligometastases.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002663.html